This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevens, G.
Right arrow Articles by Stevens, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevens, G.
Right arrow Articles by Stevens, W.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2005, p. 857-861, Vol. 43, No. 2
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.2.857-861.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Evaluation of Two Commercially Available, Inexpensive Alternative Assays Used for Assessing Viral Load in a Cohort of Human Immunodeficiency Virus Type 1 Subtype C-Infected Patients from South Africa

G. Stevens,1* N. Rekhviashvili,1 L. E. Scott,1 René Gonin,2 and W. Stevens1

Department of Molecular Medicine and Haematology, School of Pathology, University of the Witwatersrand Medical School, Faculty of Health Science and the NHLS, Johannesburg, South Africa,1 Westat, Rockville, Maryland2

Received 20 June 2003/ Returned for modification 26 September 2003/ Accepted 12 September 2003

Although human immunodeficiency virus type 1 (HIV-1) RNA is the acknowledged "gold standard" marker for monitoring disease activity in patients receiving highly active antiretroviral therapy (HAART), it remains unaffordable in resource-constrained settings. The present study investigated two commercially available kits for the detection of HIV-1 viral load markers as more affordable alternatives to HIV-1 RNA quantitation. The greatly improved heat-denatured, signal-boosted HiSens HIV-1 p24 Ag Ultra kit (Perkin-Elmer) and the ExaVir Load Quantitative HIV-RT kit (Cavidi Tech AB) were compared with the Amplicor HIV-1 Monitor (version 1.5) assay (Roche Molecular Systems Inc.). A total of 117 samples containing HIV-1 subtype C were analyzed by all three methodologies. Eighty-nine of these samples represented serial measurements from 20 patients receiving HAART. The remaining samples analyzed were from a group of treatment-naïve patients. The association between the p24 antigen assay and the RNA assay was fairly strong (R2 = 0.686). The association between the reverse transcriptase (RT) quantitation assay and the RNA assay was strong (R2 = 0.810). Both alternative assays seemed most useful for the serial monitoring of patients receiving HAART (n = 89 plasma samples from 20 patients), as all assays showed a statistically significant downward trend over time, with the trend being either linear or curvilinear. In addition, all three assays showed negative correlations with the CD4 count (CD4 count versus RNA load, r = –0.336 and P = 0.001; CD4 count versus p24 antigen level, r = –0.541 and P < 0.0001; CD4 count versus RT level, r = –0.358 and P = 0.0006). Still of major concern are both the lack of sensitivity and the wide degrees of variability of both assays. However, both assays provide a less expensive alternative to the Roche viral load assay and demonstrate the same trends during treatment.

* Corresponding author. Mailing address: Department of Molecular Medicine and Haematology, School of Pathology, University of the Witwatersrand Medical School, Faculty of Health Science and the NHLS, Johannesburg 2193, South Africa. Phone: 27 11 489-8505. Fax: 27 11 484-5812. E-mail: wendy.stevens{at}nhls.ac.za or wendy{at}dlatech.co.za.

Journal of Clinical Microbiology, February 2005, p. 857-861, Vol. 43, No. 2
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.2.857-861.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Labbett, W., Garcia-Diaz, A., Fox, Z., Clewley, G. S., Fernandez, T., Johnson, M., Geretti, A. M. (2009). Comparative Evaluation of the ExaVir Load Version 3 Reverse Transcriptase Assay for Measurement of Human Immunodeficiency Virus Type 1 Plasma Load. J. Clin. Microbiol. 47: 3266-3270 [Abstract] [Full Text]  
  • Scott, L. E., Noble, L. D., Moloi, J., Erasmus, L., Venter, W. D. F., Stevens, W. (2009). Evaluation of the Abbott m2000 RealTime Human Immunodeficiency Virus Type 1 (HIV-1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 Assays. J. Clin. Microbiol. 47: 2209-2217 [Abstract] [Full Text]  
  • Iqbal, H. S., Balakrishnan, P., Cecelia, A. J., Solomon, S., Kumarasamy, N., Madhavan, V., Murugavel, K. G., Ganesh, A. K., Solomon, S. S., Mayer, K. H., Crowe, S. M. (2007). Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings. J Med Microbiol 56: 1611-1614 [Abstract] [Full Text]  
  • Jennings, C., Fiscus, S. A., Crowe, S. M., Danilovic, A. D., Morack, R. J., Scianna, S., Cachafeiro, A., Brambilla, D. J., Schupbach, J., Stevens, W., Respess, R., Varnier, O. E., Corrigan, G. E., Gronowitz, J. S., Ussery, M. A., Bremer, J. W. (2005). Comparison of Two Human Immunodeficiency Virus (HIV) RNA Surrogate Assays to the Standard HIV RNA Assay. J. Clin. Microbiol. 43: 5950-5956 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»